Intracranial pressure (ICP) monitoring plays a crucial role in the treatment of many neurosurgical and neurological patients. It is the keystone for treating patients, especially suffering from Traumatic Brain Injury (TBI) and other medical disorders such as hydrocephalus, space-occupying lesions, non-traumatic bleeds, and cerebral oedema. The benchmark for monitoring ICP, however, is through an invasive technique which involves placement of an intraventricular catheter, but this technique is associated with many threats. Hence today, numerous noninvasive ICP monitoring methods are being evaluated with a hope to substitute the invasive methods.
What is Intracranial pressure (ICP) monitoring?
ICP monitoring is a diagnostic test that assists doctors in identifying whether high or low cerebrospinal fluid (CSF) pressure is the cause of the symptoms for trauma patients with subarachnoid haemorrhage, severe head injuries, large strokes, or structural lesions. This test measures the pressure in the head by means of a small pressure-sensitive probe that is inserted through the skull.
The ICP procedure was invented by Kellie and Monroe several years ago and is being ubiquitously used for trauma patients. With the widespread development in science and technology, several invasive and non-invasive methods for monitoring intracranial pressure (ICP) have been established and some are on the verge of development.
Why Intracranial CSF Pressure Monitoring?
Intracranial CSF Pressure Monitoring helps doctors to measure the pressure for over 24 hours or more to identify intermittent irregularities and determine how perfectly they correlate with your symptoms. A person can experience intense pressure in head even when ICP is in the normal range, but ICP can be significantly raised while he sleeps. Hence, to determine the exact cause of symptoms it is very important to keep track of pressure for a minimum period of 24 hours. Also, using this technique, doctors can observe how different head and body positions affect ICP. In some circumstances, an unusually low pressure can be observed if a person is standing for longer period of time.
Development and increased use of non-invasive ICP monitoring devices
Intracranial pressure monitoring devices are inexpensive, easy to use, reliable, and provide precise measurement of the pressure inside the head. These factors are expected to boost the demand for intracranial pressure monitoring devices market in the coming years. With an aim to eradicate or reduce all the complications, risk of infections, and haemorrhage related to the use of invasive ICP monitoring devices, several research and development activities are been conducted for the invention of non-invasive intracranial pressure monitoring devices.
Also, as per a report by Research Dive, the global intracranial pressure monitoring devices market is expected to garner US $1,625.7 Million by 2026, registering a CAGR of 3.3% from 2019 to 2026. This is mainly because of the growth in development and use of non-invasive ICP monitoring devices all across the world.
Intracranial pressure monitoring devices certainly play a significant role in determining the pressure inside the brain. It helps doctors in dealing with an ambiguous rise or drop in the skull which in turn, decreases the chances of clotting and threats to even get fatal diseases. Nowadays, the medical device producers are developing various types of products which can help scale-up the intracranial pressure monitoring and sensing techniques. Some of the top players highly active in the intracranial pressure monitoring device industry include Raumedic AG, Continental Medtronic Plc, DePuy Synthes, Integra LifeSciences Corporation, Vittamed, Focus Medical Group Inc., SOPHYSA, HeadSense Medical, Inc., Linet, Spiegelberg Gmbh, and others.